WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES

Checking

 

L'Oréal S.A. OR

ParisHousehold and personal productsFinancials to Sep 30, 2026 · Updated Nov 11, 2026

On Stock Analysis · affiliate link
OR financials
Moat score
83
ROIC
14.8%
P/E
37.5
EV/EBIT
28.5
FCF yield
3.2%
Dividend yield
1.6%
Market cap
€236.7B

Moat ranks

Score rankTied #100 of 396
Durabilitydurable
Market structureCompetitive
Pricing powermoderate

Balance sheet

6/30/26
€BDec 31Jun 30
Cash9.94.0
Securities0.00.0
Debt10.114.3
Net cash-0.3-10.3
Equity35.033.8
Leverage
Debt / EBITDA
1.37×
Debt / equity
0.42×
Leases (6/30/26)
€2.4B
Capital
Diluted shares
535M
Book value / share
€63.29
Price / book
7.0×
Net cash / share
−€19.24
Market cap
€236.7B
Enterprise value
€247.0B

Per-share record

Fiscal years and TTM
Scale
€0€25€50€75€100'16'17'18'19'20'21'22'23'2482.28'2584.82TTM
Revenue per shareCash flow per share

Key indicators

Latest: H1 '26
IndicatorLatestVs year agoLast 8 halves
Revenue growth5.8%+4.2 pts
Operating margin20.0%+0.1 pts
FCF margin13.1%+0.9 pts
Capex / revenue3.0%-0.4 pts
Research & Innovation expense€697M+4%
Product-dispute expense€169M–
Professional Products sales · 9/30/26€1.5B+12%
Professional Products sales excluding IT phasing growth+14%–
Consumer Products sales · 9/30/26€4.0B+4%

Margins and growth from reported quarters; company KPIs as reported in results releases.

About OR

L’Oréal sells beauty products through mass retailers, luxury shops, pharmacies, salons and online. Consumer Products and Luxe contributed about 37% and 35% of 2025 sales.

Revenue mix
Consumer Products Division 36.5%L'Oréal Luxe Division 35.4%Dermatological Beauty Division 16.4%Professional Products Division 11.7%
  • Brand Trust

    L'Oréal Paris and Maybelline retain globally scaled category positions, and L'Oréal Paris grew in double digits in H1 2026.

  • Capex Knowhow Scale

    Group-wide R&I spans 22 research centres, 13 evaluation centres and more than 4,000 scientists, allowing formulations and launches to be adapted across regions and brands.

  • Brand Trust

    A portfolio of 27 prestige brands supports broad luxury-beauty participation, and L'Oréal reports global fragrance leadership.

  • Contractual Exclusivity

    Long-duration exclusive licences secure beauty-development and distribution rights to fashion-house brands.

Timeline
  1. Oct 22, 2026

    The issuer confirmed completion of the Innovist majority acquisition. It also reported Mexico consumer-product supply disruptions and retailer inventory effects, which contributed to negative regional quarterly adjusted growth; no undisclosed acquisition price or cash amount is inferred.

  2. Oct 5, 2026

    Reuters, citing an unverified Wall Street Journal report, said L’Oréal hired advisers to explore US chemical-related liabilities; no completed transfer or restructuring was announced.

  3. Sep 24, 2026

    L’Oréal priced EUR2bn of bonds for corporate purposes, adding floating and fixed financing with coupons of Euribor plus 27 basis points, 3.75% and 4.00%.

  4. Sep 24, 2026

    BOLD and Nykaa announced a collaboration to take minority stakes in Indian beauty brands, expanding access to local innovation while founders keep control.

  5. Sep 10, 2026

    Arizona filed a consumer-fraud complaint against L’Oréal and its subsidiaries over chemical hair-relaxer marketing, adding a state enforcement case to product litigation; allegations are not a finding of liability.

Financial record

Fiscal year2016201720182019202020212022202320242025TTMTrendChange 2016–25
Per share (€)
Revenue44.1446.1847.8453.0849.8457.6871.1676.6981.1282.2884.82+7.2%/yr
Cash flow8.339.229.4011.1311.4912.0211.6814.1615.4616.1716.81+7.6%/yr
Earnings5.466.786.926.666.348.2110.6111.5211.9511.4411.79+8.6%/yr
Free cash flow5.976.986.888.949.7610.109.1811.3912.3913.3814.11+9.4%/yr
Capex2.362.242.512.191.731.922.502.773.062.792.70+1.9%/yr
Dividends3.093.303.563.873.874.054.846.056.657.057.25+9.6%/yr
Book value43.4044.0447.8252.2751.6242.1350.5554.1461.8165.2963.29+4.6%/yr
Diluted shares (M)565564563563562560538537536535535-0.6%/yr
Totals (€B)
Revenue24.926.026.929.928.032.338.341.243.544.145.4+6.5%/yr
Operating income4.04.44.85.14.55.77.27.78.28.48.7+8.7%/yr
Net income3.13.83.93.83.64.65.76.26.46.16.3+7.9%/yr
Free cash flow3.43.93.95.05.55.74.96.16.67.27.5+8.7%/yr
Buybacks0.50.50.50.70.010.10.50.50.50.50.5+0.0%/yr
Dividends1.71.92.02.22.22.32.63.23.63.83.9+9.0%/yr
Net cash0.51.92.84.45.5-1.9-1.4-2.6-2.5-0.3-10.3−€0.7B
Margins & returns (%)
Gross margin71.671.772.873.073.173.972.473.974.274.374.4+2.7 pts
Operating margin15.916.917.917.116.117.718.918.719.019.019.1+3.1 pts
Net margin12.414.714.512.612.714.214.915.014.713.913.9+1.5 pts
FCF margin13.515.114.416.819.617.512.914.915.316.316.6+2.7 pts
ROIC12.414.415.015.414.416.919.018.317.417.914.8+5.5 pts
Return on equity12.615.414.512.712.319.521.021.319.317.518.6+5.0 pts
R&D % of revenue3.43.43.43.33.43.23.03.13.13.13.1-0.2 pts
Stock pay % of revenue0.50.50.50.50.50.50.40.40.50.60.6+0.1 pts
Capex % of revenue5.44.95.34.13.53.33.53.63.83.43.2-2.0 pts

Change uses 2016 and 2025 only: compound annual growth for amounts, points for margins and returns, and the change in amount for net cash. A dash means no 2016 base. Trend shows the fiscal years.

TTM = two half years to Sep 30, 2026. Per-share values use diluted weighted shares.ROIC = operating income × (1 − 24.8% tax rate, the company's own over three fiscal years excluding one-offs) ÷ (equity + debt − cash and current securities). Returns show a dash when their base is negative or under 10% of revenue. Free cash flow = operating cash flow − capex. Debt is all borrowings; net cash counts long-term securities and excludes leases.

Moat

Moat scorecard

Moat score83
Strength
Confidence
Structure
Competitive
Durability
durable
Trajectory
stable
Pricing power
moderate
Segments
  • Consumer Products Division36.5%
    2 claims
  • L'Oréal Luxe Division35.4%
    2 claims
  • Dermatological Beauty Division16.4%
    2 claims
  • Professional Products Division11.7%
    1 claim

Moat claims

Applies to
Consumer Products Division
Confidence
Durability
durable
Trajectory
stableas of Oct 8, 2026
Why it holds

L'Oréal Paris and Maybelline retain globally scaled category positions, and L'Oréal Paris grew in double digits in H1 2026. An independent 2026 brand valuation ranked L'Oréal second in cosmetics, supporting consumer recognition, while its 13% value decline is live counterevidence against treating leadership as permanent.

Why stable

Consumer Products adjusted like-for-like sales grew 4.3% in H1 2026, supporting brand demand despite promotional competition and the September hair-relaxer complaint.

Indicators
  • Consumer Products sales€4.0B+4%
  • Consumer Products sales excluding IT phasing growth+4%
  • Product-dispute expense€169M
Risks
  • Indie, K-beauty and local brands scaling rapidly through social and e-commerce channels
  • Private-label and retailer-owned brands improving quality and value perception
  • Reputation shocks from product safety controversies

Profile change log

  1. Nov 11, 2026 · business change

    The issuer confirmed completion of the Innovist majority acquisition. It also reported Mexico consumer-product supply disruptions and retailer inventory effects, which contributed to negative regional quarterly adjusted growth; no undisclosed acquisition price or cash amount is inferred.

  2. Oct 8, 2026 · business change

    Reuters, citing an unverified Wall Street Journal report, said L’Oréal hired advisers to explore US chemical-related liabilities; no completed transfer or restructuring was announced.

  3. Oct 8, 2026 · business change

    BOLD and Nykaa announced a collaboration to take minority stakes in Indian beauty brands, expanding access to local innovation while founders keep control.

  4. Oct 8, 2026 · business change

    L’Oréal priced EUR2bn of bonds for corporate purposes, adding floating and fixed financing with coupons of Euribor plus 27 basis points, 3.75% and 4.00%.

  5. Oct 8, 2026 · business change

    Arizona filed a consumer-fraud complaint against L’Oréal and its subsidiaries over chemical hair-relaxer marketing, adding a state enforcement case to product litigation; allegations are not a finding of liability.

  6. Oct 8, 2026 · business change

    Henkel completed its Olaplex purchase and claimed the global number-two professional-hair position, increasing competition for L’Oréal’s salon and premium haircare brands.

  7. Oct 8, 2026 · business change

    L’Oréal signed a 50-year exclusive Gucci beauty licence due to start on 1 July 2027, subject to regulatory approvals, securing a long contract while adding transition risk.

  8. Oct 8, 2026 · business change

    L’Oréal agreed to buy a majority stake in Innovist, adding digital Indian personal-care brands if the deal closes.

  9. Oct 8, 2026 · business change

    L’Oréal completed its EUR4bn Kering Beauté purchase, adding Creed and the Balenciaga and Bottega Veneta beauty licences, with consolidation from April.

  10. Oct 8, 2026 · business change

    L’Oréal bought another 10% of Galderma for EUR4.2bn, taking its stake to 20% and changing the investment to equity-method accounting.

  11. Oct 8, 2026 · business change

    L’Oréal completed its EUR2.4bn Aēsop purchase, extending Luxe into premium skincare and branded retail.

  12. Oct 8, 2026 · business change

    L’Oréal sold The Body Shop, removing a retail business and making continuing beauty operations the comparable earnings base.

  13. Oct 8, 2026 · analyst revision

    Verified seven moat claims; added their trajectories, operating KPI histories, capital-allocation debate and management. Replaced interim segment weights with FY2025 sales and removed profit shares that excluded corporate expenses. Classified mass beauty as competitive on current industry evidence; the application score changes from 84.42 to 83.26 while claim strengths and evidence coverage remain unchanged. Matched all four divisions to sourced end markets.

Industry & peers

Peer map

0%10%20%30%40%50%60708090100Moat scoreIndustry medianORPG

Hover a point for its values; click a peer to compare. Dashed lines: industry medians.

Global mass beauty and personal care

As of Oct 9, 2026
CompetitiveLow cyclicality

Affordable and premium mass-market skin, hair, makeup, fragrance and personal-hygiene products, including oral care, sold worldwide through supermarkets, drugstores and online. Excludes prestige-only products, prescription treatments and salon labour.

  1. L’Oréal
  2. Procter & Gamble
  3. Unilever
  4. Beiersdorf
  5. Coty
  6. Kao
StocksMoatGross m.Op. m.
OR8374.4%19.1%
Industry median116960.6%14.8%
Sector median857455.3%17.0%
All stocks median3987653.1%20.0%

Moat medians cover every stock. Margin medians count only stocks with collected numbers and need at least three.

Drivers & risks

Demand drivers
  • Daily replenishment gives this market low overall cyclicality; economic weakness mainly shifts shoppers toward smaller packs, promotions and cheaper brands.
  • Rising household income in emerging countries has high influence on new beauty users and premium mass formulas.
  • Hair treatments, accessible skincare actives and fast launches support mix, while clinical evidence matters for claims.
  • Digital retail and social discovery have high influence on brand trial; retailers and online platforms increasingly control visibility.
Risks
  • Regional and digital brands can gain customers rapidly; shoppers and retailers face low switching costs.
  • Inflation in chemicals, plastic, packaging, energy and freight can reduce profit if retail price increases fail.
  • Currencies have high influence on translated multinational sales; rates have moderate influence through consumer budgets and acquisition financing.
  • Ingredient restrictions, claims standards, safety disputes and counterfeit goods can harm brand trust and require reformulation.
  • Retailer concentration, promotions and private labels can absorb manufacturers’ price increases.

Bulls & bears

Key question · as of Oct 8, 2026

Can organic market-share gains and cash generation pay for the larger brand and aesthetics portfolio while litigation, promotion and financing costs rise?

Arguments

4 forFaded: weakening or settled6 against

What to watch

  1. 1Divisional organic sales excluding IT order phasing, compared with the same markets
  2. 2Cash provided by operations, gross capex and debt after acquisitions
  3. 3Product-dispute expense, new rulings and any hair-relaxer provision

Next check: FY2026 financial statements for cash generation, litigation provisions and acquisition returns; track Mexico supply disruption and the Gucci transition due July1,2027, subject to approvals.

Sources: company filings and dated sources collected for Find My Moat; market cap as of Nov 10, 2026. Not investment advice.

Cite or reuse this data

Free to reuse, commercially too, with a credit link. See the data license.

Moat Score 83/100 by <a href="https://www.findmymoat.com/stocks/XPAR:OR">Find My Moat</a> (as of September 2026)

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.